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Neonatal hypoxic ischemia (HI) is a severe condition characterized by a complex 
pathophysiology. The lack of oxygen (hypoxia) and blood flow (ischemia) leads to neuronal 
cell death via necrosis and apoptosis, and a consequent post-ischemic inflammation. HI brain 
injury may lead to seizures, cognitive and motor impairments, and death. Worse 
neurodevelopmental outcomes have been observed in male than in female survivors, thus 
underlining sex-dependent differences. 
To date, hypothermia is the only available evidence-based treatment for neonatal HI that shows 
neuroprotection if applied within six hours after the insult. Although hypothermia reduces 
production of cytokines and metabolic stress, it was shown to not be effective in severe cases 
of neonatal HI. Additional therapies meant to alleviate the HI outcomes are therefore needed.  
In the present thesis we investigated the role of two key players involved in post-ischemic 
inflammation, namely resident microglia and infiltrating macrophages, and studied the effects 
of drug- and cell-based treatments aimed at reducing injury. 
HI was induced by occluding the common carotid artery in mouse pups that were then subjected 
to hypoxia. By investigating the dynamics of inflammatory cells in the hippocampus of injured 
mice, sex-specific differences were observed in microglia and infiltrating peripheral-
macrophages. Sequencing data revealed that macrophages are the drivers of the post-ischemic 
inflammation through significant upregulation of cytokine, chemokine and sensome markers, 
as well as activation genes. In addition, microglial cells, which were shown to downregulate 
unique signature genes upon inflammation, restored their homeostatic role within three days 
after injury in males, suggesting a different mechanistic effect in response to the 
neuroinflammatory cascade. 
The role of resident microglia was further investigated in a Tamoxifen-based depletion model 
in which HI was then performed. While no difference in the speed of microglial repopulation 
was observed between males and females, the injury progression and cytokine production 
changed in a sex-dependent fashion. Specifically, depletion aggravated neuronal damage and 
apoptosis in male mice following HI. 
In order to reduce inflammation and to induce neuroprotection, therapies involving caffeine or 
bone marrow-derived macrophage administration were assessed in this thesis.  
Caffeine, which is an adenosine-receptor competitor, is currently used in the clinic as treatment 
for neonatal apnea. As long-term follow-up studies of apneic babies treated with caffeine 
showed a reduced incident of cerebral palsy, this drug was administered at different time points 
after HI. Our results revealed a reduced lesion and improved behavioral outcomes after a single 
dose of 5 mg/kg caffeine immediately post-HI, with a reduction of the lesion and glial scar 
extent, and modulation of microglia activation and pro-inflammatory genes.  
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Bone marrow-derived macrophages were adoptively transferred 5 days after HI to investigate 
their immunomodulatory and wound healing properties. Our results showed a clear difference 
when anti-inflammatory macrophages (M2) or unpolarized control cells (M0) were 
administered. While M2 cell therapy led to functional recovery, we observed that M0 
macrophages worsened behavioral outcomes and increased the injury size. In addition, in vitro 
studies in organotypic hippocampal slices co-cultured with these macrophages showed that, 
while M2 maintained memory of their phenotype, the M0 cells became polarized towards a 
pro-inflammatory state, thus suggesting how unpolarized cells could lead to exacerbation of 
the inflammation and the consequent worsening of injury extent and behavioral performance 
observed in vivo. 
In summary, in this thesis I highlight the importance of microglia and infiltrating macrophages 
in the post-ischemic inflammatory cascade, and how caffeine and bone-marrow derived 
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1.1 BRAIN DEVELOPMENT/CLINICAL BACKGROUND 
In humans, brain developments starts when the neural plate emerges from the neuroepithelial 
cells of the ectoderm during the third gestational week (GW3) (Stiles & Jernigan, 2010). In 
GW5, progenitor cells such as radial glial cells start dividing and forming brain vasculature 
(Budday, Steinmann, & Kuhl, 2015). Synaptogenesis begins as early as GW8 (Molliver, 
Kostovic, & van der Loos, 1973) as a consequence of neurogenesis that peaks between GW8-
14 (Clancy et al., 2007) and continues through early postnatal life (Sanai et al., 2011). As 
development proceeds, other glial cells are generated. Astrocytes appear in GW15 (Roessmann 
& Gambetti, 1986), while oligodendrocyte (OL) progenitor cells appear in GW17 and then 
differentiate into mature OL up to early childhood (Rakic & Zecevic, 2003; Yeung et al., 2014). 
A fourth and ontogenetically distinct cell type, the microglia, appears in the human fetal brain 
approximately in GW5 and originates from yolk sac primitive macrophages (Ginhoux et al., 
2010; Kierdorf et al., 2013) although properly differentiated microglia are not observed until 
GW35 (Verney, Monier, Fallet-Bianco, & Gressens, 2010). These complex processes of cell 
genesis, maturation and organization that shape the developing brain continue untill post-natal 
life (Giedd et al., 1999). The perinatal period is thus a critical time for brain development, and 
injuries at this timepoint could irreperably alter the normal development and maturation of 
different cell populations.   
 
1.1.1 Perinatal brain injury  
Estimates from 2015 indicate that the global under 5-year-old mortality rate is 43 per 1000 live 
births, of which 45% of the deaths are during the neonatal period (Victora et al., 2016). 
Neonates are at high risk of perinatal brain injuries and epidemiological studies have identified 
intrapartum complications and perinatal infection as risk factors (Dammann & Leviton, 1997).  
Injuries during the perinatal period include systemic inflammation, preterm brain injury, 
perinatal asphyxia and stroke (Hagberg, David Edwards, & Groenendaal, 2016). It is notable 
that independently of the cause that leads to brain injury in term and preterm infants, post-
injury inflammation is a common feature (Hagberg et al., 2016). 
 
1.1.2 Hypoxic-ischemic brain injury 
Hypoxic-ischemic (HI) brain injury is a severe condition characterized by a complex 
pathophysiology. It is not dependent on a single event, but rather consists of a series of 
pathological responses. The primary cause is an impaired blood flow and the consequent 
dysfunction of one or more organs, typically the brain due to its high demand of oxygen and 
nutrient supply (Martin-Ancel et al., 1995; Volpe, 2001). The incidence of a moderate to severe 
HI for term babies accounts for 0.5-2 per 1000 live births in developed countries (Kurinczuk, 
White-Koning, & Badawi, 2010), but the number is even higher in low income settings 
(Costello & Manandhar, 1994).  
 Term neonates that develop hypoxic ischemic encephalopathy (HIE) display symptoms 
such as seizures, feeding and breeding difficulties, altered tonus and often present a low 
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APGAR score associated with umbilical cord acidosis (K. A. Allen & Brandon, 2011; Pierrat 
et al., 2005).  
HIE can lead to serious neurological impairments that affects motor and cognitive functions, 
and life-long consequences that range from mental retardation to cerebral palsy (CP), the latter 
which is the leading cause of motor disability in children (Volpe, 2001). 
 
Figure 1: Mechanism of HI brain injury. Lack of oxygen and glucose leads to a primary energy failure that causes an early cell 
death via necrosis. The brain reperfusion leads to a partial recovery of oxidative metabolism that causes a secondary energy 
failure and cell death via apoptosis. Long-term inflammation and astrogliosis define the tertiary phase that leads to delayed cell 
death. Image adapted from Li et al. (B. Li, Concepcion, Meng, & Zhang, 2017) and partially created with BioRender.   
 
1.1.3 Mechanisms of hypoxic-ischemic brain injury 
The collapse of blood and oxygen supply, termed ‘primary energy failure’, starts a cascade of 
events that lead to a delayed metabolic disruption referred to as ‘secondary energy failure’.  
The time between the primary and the secondary phases, the ‘latent phase’, allows a brief 
period of recovery and it varies in length ranging from hours to days (Ten & Starkov, 2012). It 
has been suggested that there is a ‘tertiary phase’ during which possible factors such as glial 
scar, persistent inflammation and epigenetic changes cause long-lasting effects and promote 
further damage (Fleiss & Gressens, 2012). This three-phase mechanism is summarised in 
Figure 1. 
 Initially, the lack of energy caused by HI inhibits mechanisms that act to maintain cellular 
homeostasis and lead to the failure of the Na+/K+ pump and the consequent Na+, Cl- and H2O 
influx (Choi, 1988). The resulting cell edema causes neuronal depolarization and the excessive 
release of glutamate, an excitatory neurotransmitter that under physiological conditions is 
usually cleared by astrocytes (Hagberg et al., 2016). The accumulation of glutamate in the 
synaptic cleft, stimulates the N-methyl-D-aspartate (NMDA) receptors which massively 
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release intracellular Ca2+ ions that activate the apoptotic cell death pathway and induce the 
production of reactive oxygen species (ROS) with ensuing mitochondrial damage (Hagberg, 
Mallard, Rousset, & Thornton, 2014). HI-induced excitotoxicity and oxidative damage 
cascades can instigate microvascular injury and blood-brain barrier (BBB) dysfunction, 
triggering a robust post-ischemic inflammation, as evidenced by microglia activation and 
cytokine release (Bona et al., 1999; Mallard, Tremblay, & Vexler, 2019; McRae, Gilland, 
Bona, & Hagberg, 1995). The role of inflammation, together with necrosis and apoptosis, is of 
critical importance in the secondary and especially tertiary phases of brain injury, suggesting a 
potential target for therapeutic intervention (Hagberg et al., 2015).     
 
1.2 NEURO-INFLAMMATION 
Inflammation is common to various forms of central nervous system (CNS) injuries and 
diseases, although is not necessarily a causative factor. Inflammation is characterized by the 
activation of different cell types including microglia and astrocytes and the production of 
inflammatory molecules. It is increasingly considered to contribute to the process of 
pathogenesis and, where appropriate, to repair (Hagberg, Gressens, & Mallard, 2012; Hagberg 
et al., 2015). In the context of neonatal HI, inflammation is critical for delayed cell death and 
contributes importantly to the progression of brain injury (Inder & Volpe, 2000; Mallard, Ek, 
& Vexler, 2018). In addition, it has been widely established that due to the release of 
inflammatory molecules and the disruption of the BBB after HI, peripheral immune cells can 
infiltrate the brain in support of local microglia (Mallard et al., 2018; Mallard et al., 2019; P. 
L. P. Smith et al., 2018; Winerdal et al., 2012). This process is summarized in Figure 2. 
 
1.2.1 CNS immune specialization 
Tissue swelling and accumulation of cells at the inflammatory site - which is common in 
peripheral inflammation - is not well tolerated in the brain due to the dangerous level of 
pressure that may arise within the skull (Callahan & Ransohoff, 2004). In addition, the delicate 
neuronal circuitry development and the limited capacity for regeneration make the brain 
particularly sensitive, thus underlining the importance of maintaining homeostatic CNS 
functions (Carson, Doose, Melchior, Schmid, & Ploix, 2006).  
 The brain has been considered as an immune privileged organ for many years, relatively 
isolated from the periphery due to the existence of the BBB (Schwartz, Moalem, Leibowitz-
Amit, & Cohen, 1999) that strictly regulates the ionic balance and prevents toxins and proteins 
from the blood affecting the CNS (Abbott, 2013). This immune privilege, although constrained 
to the cerebral parenchyma and not the ventricles, meninges and choroid plexus (Galea, 
Bechmann, & Perry, 2007), was later reconsidered after a functional network of lymphatic 
vessels lying parallel to the dural synuses were discovered (Louveau et al., 2015). 
 The isolation of the CNS is undermined during pathological conditions, being they 
infectious or traumatic, as neuroinflammation and the alteration of the BBB functionality 
attract peripheral immune cells (Mallard et al., 2018; Rayasam, Faustino, Lecuyer, & Vexler, 
2020; Schafer et al., 2012). In the context of perinatal HI, inflammation and its key players are 
important contributors to both injury outcomes and an altered development of the immature 






Figure 2: Post-ischemic inflammation. Primary neuronal death via necrosis leads to the release of DAMPs that are sensed by 
resident immune cells effectors. The latter start the inflammatory cascade by producing immunomodulators and ROS, resulting 
in a neurotoxic environment that promotes secondary cell death via apoptosis. In addition, the production of MMPs and 
chemokines induces BBB opening and the consequent infiltration of peripheral immune cells that exacerbate the inflammation 
and subsequent neuronal death. Image adapted from Li et al. (B. Li et al., 2017) and created with BioRender. 
 
1.2.2 Resident microglia 
Microglia are a primary immune cell in the brain and represent 12-15% of the CNS cellular 
component (Lawson, Perry, & Gordon, 1992). Microglia contribute to immune responses 
against infectious agents, degenerative diseases, trauma, they provide support for CNS 
development, myelination and synaptogenesis, and sustain brain homeostasis and structure 
(Casano & Peri, 2015; Nguyen et al., 2020). Microglia are a unique cell population and can be 
distinguished from other brain cells by origin, function, morphology and gene expression 
patterns (Nayak, Roth, & McGavern, 2014). Microglia derive from the yolk sac and migrate 
into the murine brain during an early embryonic stage before BBB closure (Alliot, Godin, & 
Pessac, 1999; Alliot, Lecain, Grima, & Pessac, 1991; Ginhoux et al., 2010).   
 Microglia enter the brain in an amoeboid state due to their high proliferation and 
phagocytic activity, which are behaviors also recognized during inflammatory processes 
(Kettenmann, Hanisch, Noda, & Verkhratsky, 2011). During the early phases of development, 
microglia are highly motile to compensate for their low density in the brain parenchyma 
(Smolders et al., 2017). Colonization follows a dynamic spatial pattern, with initial 
accumulation in areas with proliferating neural precursors and developing axons, only to leave 
and finally distribute when neuronal functional structures and wiring connections have been 
established (Gordon & Pluddemann, 2017). Microglial functions in the developing brain thus 
specifically range between the elimination of apoptotic cells and the support of neurogenesis 
and angiogenesis, to the contribution of the generation of new astrocytes and oligodendrocytes 
(Frost & Schafer, 2016). Little is known about early microglia colonization and maturation in 
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the human brain (Semple, Blomgren, Gimlin, Ferriero, & Noble-Haeusslein, 2013; A. M. 
Smith & Dragunow, 2014) because data have mainly been acquired from animal studies. 
 Through a series of transitions the microglial population subsequently acquires its ramified 
morphology and reaches the mature phenotype by the end of the second postnatal week 
(Bennett et al., 2016; Matcovitch-Natan et al., 2016). In the adult brain microglia are distributed 
throughout the parenchyma with region-specific densities and diversity (Grabert et al., 2016; 
Lawson, Perry, Dri, & Gordon, 1990; Silvin & Ginhoux, 2018). After initial expansion via 
proliferation, the population of microglial cells remains relatively stable throughout life and is 
maintained by self-renewal (N. J. Allen & Barres, 2009; Harry, 2013). Microglia indeed have 
a long life span and proliferate to replace dying microglial cells, thus maintaining a steady-state 
condition (Ajami, Bennett, Krieger, Tetzlaff, & Rossi, 2007; Askew et al., 2017). 
 Although in physiological conditions microglia are considered to be in a resting state, they 
monitor, scan and control the nervous tissue, building a structured network of dynamic and 
plastic cells (Salter & Beggs, 2014). They constantly move the ramified processes to survey 
and check the surroundings, sensing microenvironmental alterations (Nimmerjahn, Kirchhoff, 
& Helmchen, 2005; Tay, Savage, Hui, Bisht, & Tremblay, 2017). Under pathological 
conditions microglia undergo rapid morphological changes: they retract their long processes 
and adopt an amoeboid shape, altering their genetic profile to adapt to new functions and 
conditions (Hanisch, 2002; Hirbec et al., 2018). During this process, which is called 
‘activation’, microglia can rearrange and upregulate the surface receptors needed for changes 
in intracellular enzyme production, interaction with extracellular matrix and neighboring cells, 
and they release inflammatory and immunomodulatory molecules (Kettenmann et al., 2011; 
Nayak et al., 2014). Among all factors that microglia release, there are also chemoattractants 
such as monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein-
2 (MIP-2) that recruit other immune cells such as macrophages from the periphery (Diab et al., 
1999; Spanaus et al., 1997). 
 
1.2.3  Infiltrating macrophages 
Monocytes are innate immune cells of myeloid origin. They derive from bone-marrow 
hematopoietic stem cells, which differentiate into common myeloid progenitors under the 
regulation of macrophage-colony stimulating growth factor (M-CSF) (Cecchini et al., 1994; 
Gordon & Pluddemann, 2017). They are released into the blood circulation after maturation 
due to the chemokine C-C motif ligand 2 (CCL2), a chemokine also involved in macrophage 
attraction during pathological inflammatory conditions (Serbina & Pamer, 2006).  
Monocytes can be divided into two main groups: classical (Ly6hiCCR2+CX3CR1mid) and non-
classical (Ly6lowCCR2-CX3CR1hi)(Geissmann, Jung, & Littman, 2003). The first are 
considered highly mobile but short-lived cells that can reach the site of injury and respond to 
inflammation (Auffray et al., 2007). The function of non-classical monocytes, which are 
thought to derive from the classical ones, is not yet well established, but they have longer half-
life and patrol the vessel lumen in support of tissue homeostasis and repair (Ginhoux & Jung, 
2014; Yona et al., 2013).  
 Monocytes are particularly important during inflammatory processes because they are 
involved in the production of monocyte-derived macrophages (MDMs) characterized by the 
expression of high levels of CD45 and are positive for CD11b (Davies, Jenkins, Allen, & 
Taylor, 2013; Epelman, Lavine, & Randolph, 2014; Ginhoux & Jung, 2014). MDMs are plastic 
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cells and have the function to survey, sense and scan the surrounding environment looking for 
pathogens. Under pathological conditions, be they infections or sterile injuries, they are 
recruited via specific signaling in the affected area and assist resident macrophages in the clean-
up processes, thereby promoting a return to homeostasis (Murray & Wynn, 2011; Shi & Pamer, 
2011).   
 In the case of HI these bone marrow-derived monocytes are recruited from the circulation 
into the CNS where they differentiate into macrophages to participate in the inflammatory 
response (Hellstrom Erkenstam et al., 2016; P. L. P. Smith et al., 2018; Umekawa, Osman, 
Han, Ikeda, & Blomgren, 2015). Although discrimination of resident microglia and infiltrating 
MDMs is quite difficult due to the similarity of these two cell types (e.g. surface marker 
expression (Perry, Hume, & Gordon, 1985; Sedgwick et al., 1991)), differences in their 
respective roles have been reported (Katsumoto, Lu, Miranda, & Ransohoff, 2014; Yamasaki 
et al., 2014). The specific interplay between these two cell types during pathological conditions, 
and extravasation of MDMs in the CNS, is therefore still a matter of study. 
 
1.2.4 Phenotypes, function and nomenclature 
Both macrophages and microglia are sentinels in their specific environments and have similar 
functions (Amici, Dong, & Guerau-de-Arellano, 2017). They have the capacity to recognize 
injured or dead cells and immune mediators, to produce small signaling molecules and to 
modulate/resolve inflammation (Herz, Filiano, Smith, Yogev, & Kipnis, 2017). They are 
specialized immunocompetent cells that express a wide range of receptors on their surface. The 
most important receptors for acute inflammation are the pattern recognition receptors (PRRs), 
which are divided into many subfamilies depending on their function. Activation of PRRs by 
ligation with pathogen- or danger-associated molecular patterns (PAMPs or DAMPs) leads to 
various intracellular pathways that result for example in the production of signaling mediators, 
phagocytosis and migration (Bianchi, 2007). A family of PRRs receptors that plays a key role 
in the activation of microglia/macrophages is the Toll-like receptors (TLRs). To date, 13 
different receptors have been identified in mammals and they can be separated into subgroups 
depending on whether they are expressed on the cell surface or within intracellular vesicles. 
Although in the brain TLRs are mostly expressed by microglia, following ischemia/reperfusion 
injury TLR4 and TLR2 are also expressed by cortical neurons (Tang et al., 2007).  
 Depending on the surrounding cues and stimuli, microglia and macrophages can 
progressively polarize into specific activation states (Gordon & Martinez, 2010; Hanisch & 
Kettenmann, 2007; Harris, 2014; Lavin et al., 2014). Over time, microglial nomenclature has 
been associated with the general classification suggested to describe the ‘macrophages 
polarization paradigm’ inspired by Mills and colleagues (Mills, Kincaid, Alt, Heilman, & Hill, 
2000). They described two distinct phenotypes: M1 (pro-inflammatory or classically activated 
macrophages) and M2 (anti-inflammatory or alternatively activated macrophages). The former 
are usually associated with the production of inflammatory molecules such as IL-1β, tumor 
necrosis factor-α (TNF- α) and nitric oxide (NO) following stimulation with lipopolysaccharide 
(LPS) or interferon-γ (IFN- γ), and are highly phagocytic. The M2 phenotype is instead 
associated with the production of factors that promote tissue remodeling such as IL-10 and 
arginase-1 following stimulation with IL-4 or IL-13. However, recent investigations have 
proven that this M1/M2 model does not reflect the real activation and polarization occurring in 
vivo, where the number of stimuli that these cells are exposed to are not limited to those 
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mentioned above and extensively used in vitro (Ginhoux, Schultze, Murray, Ochando, & 
Biswas, 2016; Ransohoff, 2016).  
 
1.2.5  Signalling molecules 
There is a variety of signaling molecules involved in the chain of events following an insult 
such as HI, and cytokines, adhesion molecules and matrix metalloproteases (MMPs) are the 
key components involved in the inflammatory process (Nissinen & Kahari, 2014; Turner, 
Nedjai, Hurst, & Pennington, 2014). 
 Cytokines, which are small signaling proteins of approximately 5-20 kDa, are of particular 
importance in the development of HI-related outcomes. They are subgrouped in families 
depending on their receptor type, for example interleukins (IL), interferons (IFN) and the tumor 
necrosis factor family (TNF) (Dinarello, 2007). They are produced by different brain cells as 
well as leukocytes - including macrophages and monocytes - but also by epithelial cells and 
fibroblasts, and act as modulating agents during inflammatory processes (Kennedy & Silver, 
2016). Cytokines mediate a variety of functions by binding specific receptors and signaling in 
an autocrine, paracrine or endocrine manner (O'Shea, Gadina, & Siegel, 2013). For instance, 
they can modulate inflammation by promoting (pro-inflammatory) or hampering (anti-
inflammatory) the response (Turner et al., 2014).  
 In HI, levels of pro-inflammatory cytokines such as IL-1β, IL-6 and TNF-α are relatively 
high compared to controls as early as a few hours after HI, indicating the beginning of post-
ischemic neuroinflammation. The concentration of these cytokines in the blood and cerebral 
spinal fluid (CSF) of asphyxiated babies was reported to be positively correlated with the 
severity of brain injury, therefore underlining the importance of these molecules to define the 
extent of the HI insult (Aly, Khashaba, El-Ayouty, El-Sayed, & Hasanein, 2006). However, 
such pro-inflammatory effects are antagonized by anti-inflammatory cytokines such as IL-10, 
which appears in the serum and brain of neonatal rats 6h and peaks at 48h after injury, and is 
suggested to resolve the inflammation by modulating the functions of leukocytes and glial cells 
(S. J. Li et al., 2014). 
 Chemokines are a separate subset of cytokines whose function is explained by their name: 
chemotactic cytokines. Their role is indeed in the recruitment of leukocytes to the site of 
inflammation. To facilitate the identification of chemokines, a subdivision in four families has 
been applied depending on where the N-terminal cysteine resides: CXC, C-C, C and CX3C 
(Murphy et al., 2000). Chemokines are less specific than other cytokines, and indeed many of 
the more than 50 ligands can bind to either one or several of the 23 receptors identified to date, 
and a receptor can have more than one specific ligand (Griffith, Sokol, & Luster, 2014). In the 
specific context of asphyxiated newborn babies, high levels of CXCL8 in the CSF are 
associated with the HIE severity and poor neurological outcomes (Savman, Blennow, 
Gustafson, Tarkowski, & Hagberg, 1998). CCL2, also known as MCP-1, is considered among 
the most important chemokines in HI. It is significantly upregulated in microglia and highly 
associated with the infiltration of macrophages and neutrophils at the injury site (Faustino et 
al., 2011; Galasso et al., 2000), as well as  CCL7, CXCL1, CCR1 and CCR5, which were also 
observed to be upregulated after HI (Hedtjarn, Mallard, Eklind, Gustafson-Brywe, & Hagberg, 
2004)  
 There are other signaling molecules that do not belong to the cytokine family, and they are 
MMPs and ADAMs (A disintegrin and A metalloproteases), or soluble adhesion molecules. 
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MMPs are zinc-dependent enzymes important in the maintenance of the function and integrity 
of physical barriers, as well as in the regulation of inflammatory mediators. They are classified 
depending on their structure and cellular localization (Nissinen & Kahari, 2014; 
Vandenbroucke & Libert, 2014). ADAMs are proteases similar to MMPs due to the zinc-
dependent activity, and their role is to support the formation of adhesion molecules (Weber & 
Saftig, 2012). The latter are small molecules that exist in soluble isoforms and are important 
for intercellular communication and cell-to-cell contact. They are divided into integrins, 
selectins (E-, P- and L-selectins), and immunoglobulin family members (e.g. VCAM, ICAM). 
HI upregulates the expression of many adhesion molecules, especially VCAM-1 and ICAM-1, 
that have been suggested to play a critical role in monocyte trafficking and recruitment within 
the brain, thus playing a fundamental role in the injury cascade (Hedtjarn et al., 2004; Lai et 
al., 2017; Zonneveld et al., 2014).     
 
1.3 THERAPIES 
Perinatal asphyxia is an important social burden and to date several studies have been 
conducted in order to assess different approaches to treat HIE.  
 As previously described, HI involves an ongoing injury process in which the damage and 
the severity are connected to the duration of this process and its extent. In order to achieve a 
neuroprotective effect it is thus necessary to interrupt this chain of events. Although the interval 
between the primary and the secondary energy failure, called the latent phase, was suggested 
to represent an optimal therapeutic window for clinical intervention, the correct identification 
of the resolution of the primary energy failure and the beginning of this latency period in 
newborn children is difficult to establish (Cotten & Shankaran, 2010).  
 Encouraging data from preclinical studies in perinatal animal models have demonstrated 
that therapies applied during the latent phase lead to a successful reduction in brain damage, 
possibly by modulating the secondary energy failure phase (K. A. Allen & Brandon, 2011). 




Hypothermia, which is currently the only available therapy to ameliorate HIE outcomes, 
consists of the progressive reduction of body (or head) temperature down to approximately 
33°C within a 6h-window after the birth of an asphyxiated term baby, for a maximum of 72h 
(Perlman et al., 2015). By doing so the brain metabolism is reduced by approximately 5% for 
each 1°C decrease in body temperature, delaying the onset of anoxic cell depolarization, 
intracellular calcium influx, and the consequent glutamate and aspartate release (Laptook, 
Corbett, Sterett, Garcia, & Tollefsbol, 1995). Additionally, recent studies reported that 
hypothermia is involved in the modulation of inflammatory pathways by reducing 
proinflammatory cytokines, and attenuating microglia proliferation and neurotoxicity (Orrock 
et al., 2015; Seo et al., 2012; Sheth, Brito, Mukherjea, Rybak, & Ramkumar, 2014).  
 Clinical trials have indeed demonstrated that hypothermia treatment in newborn babies 
with moderate HIE reduced neurological sequelae and long-term prognosis (Shankaran, 2012), 
even though approximately half of them still displayed major neurological disabilities 
(Azzopardi et al., 2014). Although many studies have shown the positive effects of 
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hypothermia, this treatment is not free from side-effects, including pulmonary hypertension, 
coagulopathies and separation from the mother (Jacobs et al., 2013). In addition, the tight time-
window of application and the need for intensive care indicate the need for additional 
treatments for hypoxic ischemic brain injury in neonates.  
 
1.3.2 Caffeine  
Caffeine is the most commonly used psychoactive drug worldwide (EFSA Panel on Dietetic 
Products & Allergies, 2015). It is a well-known methylxanthine whose hydrophobic properties 
allow it pass through all biological membranes, including the BBB, and guarantee an easy 
penetration of the CNS (Lachance, Marlowe, & Waddell, 1983; Tanaka, Nakazawa, Arima, & 
Iwasaki, 1984). Compared to other methylxanthines, caffeine is more easily absorbed, has a 
wider therapeutic range and longer half-life, and so it is preferably used in the clinic (Bertil B 
Fredholm, 2010). 
 Specifically, caffeine is a non-specific adenosine receptor (AR) antagonist and binds to 
some extent to three of the four ARs, denoted as adenosine A1, A2A, A2B and A3 receptors, with 
a preference for A1 and A2A in normal physiological conditions (B. B. Fredholm, AP, Jacobson, 
Linden, & Muller, 2011). In the brain these last two receptors are expressed in the pre- and 
post-synaptic sites of neurons, but are also present in other cells such as oligodendrocytes, 
astrocytes and of particular interest for this thesis, in microglia (Sheth et al., 2014). Caffeine is 
safely used in the clinic to treat birth apnea (Abu-Shaweesh & Martin, 2017) and follow-up 
studies have shown a decrease in CP and cognitive delay incidence at 18 months of age 
(Schmidt et al., 2007). Moreover, pre-clinical studies have reported a neuroprotective effect of 
caffeine in experimental models of neonatal asphyxia (Bona, Aden, Fredholm, & Hagberg, 
1995). Caffeine was additionally proven to reduce: LPS-induced brain inflammation in adult 
rats (Brothers, Marchalant, & Wenk, 2010); TNF-a production in cord blood monocytes 
stimulated with LPS (Chavez-Valdez, Ahlawat, Wills-Karp, & Gauda, 2016); and TNF-a, 
PGE2 and NO in BV2 microglia exposure to LPS in vitro (Kang et al., 2012).     
 Despite the beneficial effects that caffeine appears to have, a series of studies have 
suggested that an inappropriate dose or treatment duration may have detrimental effects in the 
developing brain and its functions (Atik et al., 2017). If administered too early and for a long 
period of time, caffeine reduced myelin synthesis in newborn rats in a dose-dependent manner 
(Fuller & Wiggins, 1981). Similarly, another study reported reduced proliferation of neural 
stem cells and decreased formation of astrocytes in newborn mice as result of caffeine treatment 
(Desfrere, Olivier, Schwendimann, Verney, & Gressens, 2007). Hence, the appropriate 
combination dose/duration/timing of the treatment has yet to be found. 
 
1.3.3 Cell-based treatments 
Cell-based therapies have recently drawn attention due to their encouraging results in 
experimental studies both at clinical and animal levels, suggesting their potential application in 
preventing or modulating perinatal brain injuries.  
 The most frequently used cell types in these studies are mesenchymal stem cells (MSCs) 
from various tissue origins, umbilical cord blood cells (UCBCs) and, recently, also amniotic 
epithelial cells (AECs): all tissues that allow autologous administration reducing the chances 
of rejection. Additional pros of these cell types are the minimal ex vivo manipulation and 
storage properties, the availability at birth, and the non-invasive techniques to collect them 
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(being the cells obtained from tissues that would otherwise be discarded) (Castillo-Melendez, 
Yawno, Jenkin, & Miller, 2013).  
 The mechanisms of action of these cells seem to include multiple aspects. They are all 
immunomodulatory and have anti-inflammatory properties, reduce apoptosis and oxidative 
stress and enhance the regenerative process by secreting various factors and promote 
angiogenesis and neurogenesis (Glenn & Whartenby, 2014; Nabetani, Shintaku, & Hamazaki, 
2018). UCBCs were indeed shown to: inhibit microglial activation following HIE (Pimentel-
Coelho et al., 2009); to attenuate reactive gliosis and reduce the infiltration of leukocytes into 
the brain by restoring the BBB (Wasielewski, Jensen, Roth-Härer, Dermietzel, & Meier, 2012); 
and were proven to reduce production of TNF-α and increase levels of IL-10 in the spleen of 
rats with HI (Vendrame et al., 2006). Administration of UCBCs in animal studies of HIE has 
also resulted in functional recovery such as improved sensorimotor reflexes and motor 
performance, and had neuroprotective effects if given intraperitoneally (i.p) soon after the 
lesion (Meier et al., 2006; Pimentel-Coelho et al., 2009). Interestingly, later treatments were 
also reported to be beneficial with intravenous (i.v) administration of UCBCs a week after HI. 
However, other studies reported controversial results, stating the lack of beneficial effects of 
UCBCs i.v if given 24 or 48h after injury (de Paula et al., 2009; Ohshima et al., 2016). 
 For MSCs, an increase of OL progenitors, mature OL and myelin formation in the 
ischemic hemisphere were all observed in the pioneering study of van Velthoven and 
colleagues (van Velthoven, Kavelaars, van Bel, & Heijnen, 2010). A recent study showed that 
P7 rats receiving MSCs i.v three days after HI made less mistakes in the beam walking test, 
had increased brain volume and enhanced synaptogenesis (Sakai et al., 2018). Additionally, it 
was observed that P9 mice pups receiving MSCs intranasally after HI had improved object 
recognition and barn maze test perormance, preserved white matter, reduced leukocyte 
infiltration and microglial downregulation (Herz et al., 2018). Similarly, MSCs were also 
protective when administered 10 days after HI, reducing the number of activated microglia and 
changing their polarization towards an anti-inflammatory phenotype, and limiting the 
astrocytic scar near the lesion (Donega et al., 2014). 
 In the last decade there has been a growing interest in human AECs and their reparative 
properties. Recent data in a neonatal mouse model of systemic inflammation combined with 
hyperoxia has shown a reduction of apoptosis and astrocyte areal coverage after treatment with 
hAECs, and increased microglia density and activation. However, when co-cultured in vitro 
with LPS-stimulated microglia, hAECs increased microglial phagocytic activity and decreased 
their pro-inflammatory phenotype (Leaw et al., 2017). Additionally, in a model of pulmonary 
inflammation in preterm lambs, hAECs reduced pro-inflammatory cytokines and macrophage 
presence in the lungs (Melville et al., 2017), suggesting a similar immunomodulatory effect in 
multiple organs. 
 
1.4 SEX DIFFERENCES 
It has long been acknowledged that newborn boys have a higher risk for complications during 
the neonatal period than do girls, and that they also are more prone to present with 
neurodevelopmental impairments (Wood et al., 2005). Infants with HI injury show 
impairments in language/speech and visual attention, deficits in learning, memory and 
executive functioning, display poor performance on spatial memory tasks and have lower IQ 
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scores. Among these, male neonates are reported to have worse outcomes compared to females 
with similar injury (Aylward, 2002).   
 Similarly, sex-specific impairments have been also observed in behavioral outcomes of 
experimental animals subjected to HI. As recently summarized by Netto and colleagues, female 
rats showed greater memory deficits, while males instead had greater motor impairments 
(Netto, Sanches, Odorcyk, Duran-Carabali, & Weis, 2017).  Although the nature of the specific 
mechanisms explaining this difference between males and females remains unclear, recent 
studies have identified several biological processes known to play key roles in the long-term 
outcomes. In fact, data from preclinical studies show also that: 1) male animals are more 
susceptible to oxidative stress; 2) cell death is mainly dependent on caspase activation in female 
rats; and 3) the microglial response in the male brain is more pronounced during the chronic 
phase of inflammation compared to in females (Charriaut-Marlangue, Besson, & Baud, 2017). 
In particular, microglia are reported to have a sexual dimorphisms in the neonatal brain in 
physiological conditions, with differences evident in microglial cell shape and density over 
time and in different brain regions (Lenz & McCarthy, 2015; Schwarz, Sholar, & Bilbo, 2012).  
Considering the evidence supporting sexual dimorphism in this injury model, we kept this 











The main aim of this thesis was to characterize post-ischemic neuroinflammation and to 





1. to characterize resident microglia and infiltrating macrophages in the hippocampus 
after HI, and to define possible sex-specific differences. 
 
2. to study the role of microglia and effects that its depletion has on HI brain injury in a 
model of tamoxifen-based microglia-depletion. 
 
3. to investigate whether caffeine exerted neuroprotection after HI, and to define the 
therapeutic time-window. 
 
4. to study the effects of adoptive transfer of bone marrow-derived macrophages in 







A detailed methodology description is provided in each manuscript. In this section I will 
therefore focus on ethical considerations and I briefly describe the in vivo and in vitro models 
of injury, and the main techniques.  
3.1 ETHICAL CONSIDERATIONS 
All studies in this thesis were approved by Swedish Ethical Committee for Animal Research, 
Stockholms Norra Djurförsöksetiska Nämnd, and following local and regional guidelines and 
the Directives N249/13, N94/15 and N126/16. 
 All mice were pathogen-free and were bred in house. The dams and pups had free access 
to pelleted food and were housed in open cages with standard enrichment, and daily monitoring 
in accordance with local institutional guidelines.  
 Special effort was made to minimize animal suffering and to reduce the number of animals 
used to what was deemed necessary, considering the variability of each model, for the 
objectives of each experiment in accordance with the ‘three R’s’ (refine, reduce and replace). 
3.2 ANIMALS  
It is of particular importance to choose the right strain of animals for the model of injury meant 
to be studied. In the context of neonatal HI, a certain degree of susceptibility or resistance to 
brain injury was previously reported when using CD1 and 129Sv mice, respectively. As the 
degree of brain damage in C57BL/6 mice was correlated with increasing duration of hypoxia, 
thus making this strain intermediately sensitive to HI (Sheldon, Sedik, & Ferriero, 1998), we 
chose mice on the C57BL/6 background for this thesis. 
Wild type mice were used in Paper III to study the effects of caffeine treatment after neonatal 
HI, whereas genetically modified mice on the C57BL/6 background were used for all other 
studies.  
 In Paper II, Cx3cr1EYFP-CreER mice, which express the Cre-ERT2 fusion protein and have 
resident microglia (CX3CR1+) labelled with enhanced yellow fluorescence protein (EYFP), 
were crossed with RosaDTA mice,  which carry a loxP-flanked stop cassette associated with an 
attenuated diphtheria toxin (Lund et al., 2018). Mice with genotype Cx3cr1CreER-
EYFP+/Rosa26DTA+/− (called DTA+, microglia-depleted mice) and Cx3cr1CreER-
EYFP+/Rosa26DTA−/− (DTA-, control mice) were included in this study and tamoxifen was 
administered intraperitoneally (50 mg/kg) at P8 and P9 to both groups. 
 Lastly, CX3CR1GFP mice, where green fluorescent protein (GFP) labels resident microglia 
(CX3CR1+), were crossed with CCR2RFP mice, where red fluorescent protein (RFP) labels 
peripheral monocytes (Ly6ChiCCR2+CX3CR1−) to discriminate between two distinct 
populations of cells (Saederup et al., 2010). The resulting CX3CR1GFP/+/CCR2RFP/+ mice were 
used in Paper I to characterize the role of these two cell types during the post-HI inflammatory 
cascade, and in Paper IV to identify the adoptively transferred heterologous bone-marrow 
derived macrophages from autologous GFP+ and RFP+ cells. 
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3.3 IN VIVO MODEL OF NEONATAL HYPOXIA-ISCHEMIA  
In order to perform an accurate reproduction of neonatal HI in mice, postnatal day 9-10 (P9-
P10) pups of both sex were selected for the experiments. The choice of age was based on a 
previous study that reported, after comparing brain development of humans and rodents 
(specifically looking at neuroanatomy, cell proliferation, synaptogenesis, myelination, and 
inflammation), that the level of brain maturation in term newborn infants is equivalent to P7-
P10 pups (Semple et al., 2013). 
 The most commonly used model for neonatal HI derives from the Levine technique 
(Levine & Klein, 1960), later modified by Rice and Vannucci (Rice, Vannucci, & Brierley, 
1981) and adapted again by Sheldon and colleagues (Sheldon et al., 1998). This model consists 
of exposure to systemic hypoxia after unilateral common carotid ligation. The simple ligation 
procedure is not sufficient to create an ischemic event in experimental animals due to extensive 
collaterals. The addition of hypoxia leads to vessel vasodilation that, in combination with the 
decreased blood pressure, creates a reduced cerebral flow in the ipsilateral hemisphere, thereby 
inducing unilateral brain damage (Vannucci & Hagberg, 2004). 
In this thesis, unilateral ligation (Paper I) or unilateral electrocoagulation at 8 Watt (Papers II 
- IV), of the right carotid artery was carried out via midline neck incision under isoflurane 
sedation and local anesthesia to minimize pain and distress. The surgery took approximately 3-
5 minutes per mouse. Pups were next returned to their mother for feeding purposes and then 
subjected to hypoxia (10% O2 in 90% N2 at 36˚C) for 50 (Papers I - II) or 60 minutes (Papers 
III - IV). There was little mortality, no severe illness or need for early euthanasia. During sham 
operation the carotid artery was visualized and isolated but not occluded. 
3.4 MICROGLIA DEPLETION MODELS 
In the past few years many strategies, be they pharmacological or genetic, have been developed 
to efficiently deplete microglia. Administration of CSF-1R inhibitors were shown to 
successfully pass through the BBB and to deplete microglial cells without otherwise affecting 
the mice, but repopulation was evident soon after interruption of the treatment. As an 
alternative, liposomal clodronate has been also implemented to deplete microglia, although it 
was reported to lead to alteration of mice social and learning behavior (J. Han, Harris, & Zhang, 
2017). 
 A more specific option to the pharmacological depletion is the implementation of genetic 
models to ablate microglia. Examples include transgenic mice expressing the suicide gene 
herpes simplex virus thymidine kinase (HSVTK) under the CD11b promoter, via 
administration of the pro-drug ganciclovir, or CX3CR1CreER transgenic mice that drive 
diphtheria toxin receptor (DTR) expression upon Cre-mediated recombination, via 
administration of DTR. Both these models reach about 90% of microglia depletion, with a 
repopulation speed of 5 days (J. Han et al., 2017). 
 An improved model of the genetic depletion, which was used in Paper II, involves the 
implementation of Cx3cr1CreER mice crossed with R26DTA mice (Lund et al., 2018). This 
model is based on the CreER/lox system, where the DNA flanked between the loxP-specific 
sites is excised by CreER-recombinase, a ligand-dependent Cre-recombinase that is activated 
by administration of tamoxifen to the animals. This system leads to an almost complete 
depletion of the microglial niche (>95%). 
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3.5 BEHAVIORAL TESTS 
HI induces brain damage in the hippocampus, striatum/thalamus, cerebral cortex and 
subcortical/periventricular white matter (Rice et al., 1981; Vannucci & Hagberg, 2004).  
To identify any modulatory effect of our treatments, experimental mice underwent behavioral 
tests 2 weeks post-injury for the caffeine treatment (Paper III) project, or 3 weeks post-injury 
in the case of cell treatment (Paper IV). The tests were performed from a calm and unperfumed 
operator blinded to the treatment and with minimal handling to allow their natural behavior and 
to minimize stress.  
Specifically, the following tests were used: 
Beam walk test: this test is useful to evaluate their balance and fine movements (Goldstein & 
Davis, 1990). Mice are allowed to walk on a beam (0.7 cm wide, 60 cm long) elevated from 
the ground (50 cm high) and the number of mistakes is calculated (Aden et al., 2002).  
Open field: this is a simple locomotor activity test that involves the observation (BIOBSERVE 
GmbH Software, St. Augustin, Germany) of the animal movements and explorative behavior 
within an open arena (50 cm per side) for 30 min.  
Rotarod: this is a sensorimotor test that assesses coordination, where animals are placed on a 
rotating cylinder (Ugo Basile), left to walk for 300 seconds with increasing speed (4 to 40 rpm), 
and the latency calculated over an average of 5 trials. 
3.6 EX VIVO MODEL OF HIPPOCAMPAL ORGANOTYPIC SLICES AND 
OXYGEN GLUCOSE DEPRIVATION 
In order to reproduce the neonatal asphyxia in vitro we used an organotypic culture of 
hippocampal slices using the Stoppini technique (Stoppini, Buchs, & Muller, 1991). Briefly, 
P6-P7 pups were decapitated, their brains dissected and sliced at 300 μm, and the hippocampi 
were isolated and cultured on membrane inserts for up to a week. The choice of the mice age 
is based on the high degree of plasticity of the tissue that can therefore resist the mechanical 
trauma during slice preparation (Q. Li, Han, & Wang, 2016).  
 To mimic the effects of hypoxia-ischemia and reperfusion injury in slices, they are 
subjected to oxygen-glucose deprivation because effects such as cell death, excitotoxicity, and 
oxidative stress are greatly simulated in the in vivo microenvironment (Q. Li et al., 2016). 
As slices can also be co-cultured with other cells it is also a useful tool to assess therapeutic 
effects. In Paper IV, M0 or M2 macrophages were co-cultured after OGD. 
 This ex vivo model has multiple advantages as it produces results in a short time period 
and in a precisely controlled system, preserving the three-dimensional cellular network. 
Organotypic slices are then to be considered a faster method than in vivo study, as it is possible 
to assess also specific pathways, and a more accurate method than the in vitro one, as the 
heterogeneity of the tissue is maintained.  
3.7 TRANSCRIPTOMICS 
During the past decade the interest in omics studies has been the center of scientific research, 
and  new generations of techniques have been implemented to define the whole genome and 
transcriptome (Stark, Grzelak, & Hadfield, 2019). RNA sequencing has been extensively used 
in biological and biomedical fields to study the mechanisms of complex diseases, to determine 
different cell population phenotypes or to identify biomarkers for clinical purposes (Wang et 
al., 2020).  
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 In this thesis, we used bulk RNA sequencing to determine differentially expressed genes 
(DEGs) and signature markers between GFP+ resident microglia and RFP+ infiltrating 
macrophages. In order to do so, these two populations of cells were isolated using FACS 
sorting, RNA was extracted and converted into cDNA that was then sequenced. To gain an 
estimate of the expression level of each gene, cDNA fragments were aligned and mapped to a 
known transcriptome base.  





4 RESULTS AND DISCUSSION 
PAPER I: SEX-DEPENDENT AND -INDEPENDENT INFLAMMATORY PATTERNS 











































To study the interplay between resident microglia and infiltrating macrophages in the 
hippocampus after HI, and to determine if there is a sex-specific variability 
Background: 
Upon brain injury peripheral macrophages that infiltrate the brain parenchyma express a 
variety of common markers with resident microglia, thus making it difficult to identify the 
specific role of these two distinct populations of cells following HI.  
Hypothesis:  
Resident microglia and infiltrating macrophages have different functions during the post-
ischemic neuroinflammation, and there are sex-specific differences.  
Results:  
RFP+  cells infiltrate the hippocampus peaking 1 day after injury and decrease over time, 
being almost absent after a week. GFP+ cells have a slow start and peak 3 days post-HI, 
keeping high density till 7 days after injury. There is no sex-specific difference in the cell 
densities. Transcriptomic analysis shows that RFP+ cells have the greatest upregulation of 
inflammatory genes at the 1-day time point compared to the GFP+ cells or the 3-day time 
point. In addition, males GFP+ cells at the 3-day time point show a close clustering with 




In Paper I we investigated the role of resident microglia and infiltrating macrophages after HI. 
We used CX3CR1GFP/+/CCR2RFP/+ transgenic mice to selectively identify these two populations 
of cells. We started by reproducing similar injuries in both male and female mice, in order to 
have similar starting conditions, and we quantified the number of GFP+ and RFP+ cells in the 
ipsilateral hippocampus at different time points after HI. We saw that RFP+ cells peaked 1 day 
after injury and that their numbers slowly decreased over time, whereas GFP+ cells significantly 
increased 1 day post injury, peaking 3 days after HI and maintaining a plateau level until the 1 
week time point. We did not observe a sex-specific difference in peripheral macrophage 
infiltration, in contrast to previous findings (Mirza, Ritzel, Xu, McCullough, & Liu, 2015; 
Villapol et al., 2019), nor did we detect sexual dimorphism in microglial cell density in either 
controls or injured mice (Guneykaya et al., 2018; Lenz & McCarthy, 2015; Schwarz et al., 
2012). 
 Given the small number of RFP+ macrophages infiltrating a week after HI, we decided to 
proceed by further analyzing these two cell types only at the 1 and 3 day time points. GFP+ and 
RFP+ cells were sorted separately from injured or control animals, and quantitative 
transcriptomic analysis was performed using RNA Smart-Seq technique (Picelli et al., 2014). 
We then analyzed bulk RNA-sequencing specifically looking into time, cell-type and sex 
parameters, and including the following groups: GFP-1d, GFP-3d, RFP-1d, RFP-3d, control-
1d (GFP) and control-3d (GFP). An unsupervised analysis of the samples revealed that the two 
controls cluster together, while RFP and GFP samples showed specific differences over time. 
In detail, both the cell types were more diverse from the controls 1 day than 3 days after injury.  
 To better characterize this temporal pattern of GFP+ and RFP+ cells and to understand what 
are their specific roles in the post-ischemic inflammation, we next focused on the differentially 
expressed genes (DEGs, q<0.05) (Figure 2C). Analysis of the top 50 most-significant DEGs 
was then performed. An upregulation of apoptotic signaling genes 1 day after HI was observed 
in GFP+ cells, whereas at the 3 day time point the same samples had an upregulation of genes 
in cell cycle, lipid metabolism and reorganization of synaptic activity. Similarly, similar 
analysis in RFP samples revealed that genes involved in inflammation, immune-response 
signaling, cell adhesion, chemotaxis, and extracellular matrix organization were upregulated 
after 1 day, while a clear upregulation of genes involved in lipid metabolism and transport was 
observed after 3 days. 
 As HI brain injury leads to a variety of endogenous inflammatory signals that promote 
either pro- or anti-inflammatory phenotypes at different stages of disease progression 
(Hellstrom Erkenstam et al., 2016; P. L. P. Smith et al., 2018), we analyzed the expression of 
genes related to M1 or M2 activation phenotypes. Interestingly, we observed that infiltrating 
macrophages expressed higher upregulation of genes belonging to both polarization states 
indicating that, upon entry to the brain, these RFP+ cells rapidly activate and become the drivers 
of the inflammatory cascade.  
 Since the production of signaling molecules is highly dependent on the inflammatory 
environment (Colonna & Butovsky, 2017; Harris, 2014; Hickman et al., 2013), we analyzed 
specific families of genes including chemokines, cytokines, PRR and sensome markers. 
Similarly to the previous analysis, the RFP group had the highest upregulation of genes 
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belonging to the PRR and sensome families 1 day after injury, highlighting the reactivity of 
these cells during post-ischemic inflammation. In addition, we observed a specific upregulation 
of chemokine receptors in the RFP-1d group, and a higher expression of cytokines and 
chemokines genes in the GFP-1d group. As previous studies have reported a sexual 
dimorphism after neonatal HI, in both the acute (Mirza et al., 2015) and chronic (Al Mamun, 
Yu, Romana, & Liu, 2018) phases of inflammation, we analyzed the DEGs in the groups in 
question. Sex-related differences were not observed 1 day after HI, but were at the 3-day time 
point. Among the DEGs, Cx3cr1 and Siglech genes, which are also considered microglia-
unique markers, were more upregulated in males than in females in both cell types. 
 We therefore proceeded by analyzing microglia signature genes. It is known that upon 
inflammation microglia downregulate unique genes, and it is also known that RFP+ cells do 
not express these genes (Butovsky et al., 2014; Buttgereit et al., 2016; Krasemann et al., 2017). 
In accordance with the literature we observed that microglial signature genes were upregulated 
in control groups and downregulated in the RFP groups. As expected, such genes were 
downregulated in the GFP samples 1 day post-HI due to the activation of microglial cells during 
inflammation and, to a great extent these markers were also downregulated in the female GFP 
samples 3 days after HI. Surprisingly, the expression of the microglia-unique genes in the male 
GFP samples was almost at the level of controls at the 3-day time point. The UMAP clustering 
confirmed these findings, with the GFP+ cells from males clustering with the controls 3 days 
after HI.   
 Emerging evidence of sexual dimorphism in microglia (Schwarz et al., 2012) and 
microglia responses to specific environments (Thion et al., 2018) suggest a different regulatory 
mechanism in males and females that may affect the post-ischemic inflammatory cascade and 
the consequent infiltration of immune cells. It is known that microglial metabolic mechanisms 
are of fundamental importance to their ‘surveying’ functions under physiological conditions, 
and that disturbance in this equilibrium can be associated with changes in microglial lipidome 
and pro-inflammatory phenotype (Chausse, Kakimoto, & Kann, 2020). Therefore, further 
analyses are needed to evaluate how HI brain injury affects the microglia lipidome and 




PAPER 2: AGGRAVATED BRAIN INJURY AFTER NEONATAL HYPOXIC 

















































To study the effects the effects of HI brain injury in a model of tamoxifen-based microglia-
depletion. 
Background: 
Microglia are the brain phagocytes that scan and control the environment during 
physiological states. Upon injury, they undergo a structural change and they engulf cell 
debris and orchestrate the post-ischemic inflammation.  
Hypothesis:  
Microglia have a protective role during neonatal HI and depletion exacerbates the 
outcomes.  
Results:  
Tamoxifen administration at P8-9 resulted in >99% of microglia depletion in DTA+ mice 
that persisted with 97% at P13. HI brain injury showed no difference in lesion extent 
between DTA+ and DTA- female mice, but DTA+ male mice had a significantly larger 
infarct volume than did DTA- male mice. DTA+ mice of both sexes had a higher density of 
apoptotic cells in different brain regions compared to their respective DTA- mice. In 
addition, ELISA analysis revealed that DTA+ mice of both sexes had significantly lower 




In Paper II we studied the effects of HI brain injury in a novel model of microglia depletion. 
In the past few years, the role of microglia has been broadly investigated using several methods 
to deplete these cells (J. Han et al., 2017). The most common ones use pharmacological agents 
to ablate microglia. However, due to the time needed to reach an acceptable level of depletion, 
or the unselective cell damage, these models are not suitable for neonatal studies (Faustino et 
al., 2011; X. Han et al., 2019). The Harris lab has recently developed a genetic microglial-
depletion model crossing Cx3cr1EYFP-CreER mice with RosaDTA mice (Lund et al., 2018) based 
on tamoxifen administration. We optimized the dose (50 mg/kg) and timing (P8 and P9) for 
tamoxifen administration in mice with either Cx3cr1CreER-EYFP+/Rosa26DTA+/− (called DTA+, 
microglia-depleted mice) or Cx3cr1CreER-EYFP+/Rosa26DTA−/− (DTA-, control mice) genotypes. 
This protocol induced > 99% microglia depletion, as judged by Iba1+ positive cell counting, by 
P10 and this was maintained quite stably until P13 with a rate of depletion > 97%, making it a 
suitable model to study the effects of HI. Microglia repopulation then proceeded faster, with a 
rate of 60-70% depending on the brain region by P17 where non-specific clustering of 
repopulating cells was observed. Complete repopulation was observed at P24 with a slightly 
higher number of microglial cells in the DTA+ mice. Such overpopulation was consistent with 
previous reports of pharmacological depletion (Huang et al., 2018).  
 HI was performed at P10 in animals belonging to both groups and both sexes and, given 
the variability of repopulation at P17, we assessed changes in microglial proliferation and 
injury progression at P13. Using flow cytometry we analyzed EYFP+ microglia in the ipsi- and 
contra-lateral hemispheres of injured mice, as well as in sham animals. We did not observe any 
difference in the repopulation rate after injury, and this was also confirmed with 
immunohistochemical analysis for the EYFP marker. 
 We then proceeded evaluating the effect of microglia depletion on HI brain injury. By 
contouring MAP2 unstained tissue we found that DTA+ males had a larger lesion compared to 
DTA- males, and that DTA+ males had a larger lesion compared to DTA+ females. Similar 
findings were also observed in a model of adult stroke after pharmacological depletion 
(Faustino et al., 2011). This sexual dimorphism in the injury size after microglial ablation could 
be also related to specific characteristics of microglial cells, such as the ability to migrate faster 
in males than in females (Schwarz et al., 2012; Weinhard et al., 2018; Yanguas-Casás et al., 
2018) and this may have protective effects in non-depleted mice. 
 Next, we quantified neuronal TUNEL-related apoptosis and we observed that the majority 
of TUNEL+ cells clustered in the NeuN unstained area, which overlapped with MAP2 
unstained tissue. DTA+ males had a higher number of TUNEL+ cells compared to DTA- males 
in the cerebral cortex, thalamus and caudoputamen. Similarly, DTA+ females had a higher 
number of TUNEL+ cells compared to DTA- females in the hippocampus and thalamus. When 
sexes were compared we observed a tendency towards exacerbated apoptosis in males 
compared to in females in most areas of interest. Such differences seem to be associated with 
mitochondrial metabolism and apoptotic mechanisms previously reported to differ between 
sexes in physiological and pathological conditions (Demarest, Schuh, Waddell, McKenna, & 
Fiskum, 2016; Weis et al., 2014; Zhu et al., 2006). 
 Finally, we performed gene expression analysis to define whether microglia depletion had 
an effect on cytokine and chemokine production at P13, following HI at P10. Our results 
revealed a reduced expression of IL10 and TGFβ genes in DTA+ males compared to in DTA- 
males, while among females only TGFβ had a reduced expression. However, no difference was 
observed at P10, indicating a similar starting condition for all mice. Our findings are quite 
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moderate compared to previous studies in which adult stroke in microglia-depleted animals led 
to significantly increased levels of pro-inflammatory cytokines (Jin et al., 2017). However, this 
could be due to the fact that we assessed gene expression during a sub-acute phase of injury.  
 Based on the outcomes of the gene expression analyses we measured protein levels. DTA+ 
mice of both sexes had lower levels of IL-10 and TGFβ compared to DTA- mice. In addition, 
an increase of TGFβ was observed in injured DTA+ mice of both sexes compared to shams, 
while only male DTA- mice had higher levels of TGFβ compared to shams. These findings 
suggest that microglia have a fundamental role in producing IL-10 in mice, as depletion leads 
to undetected levels of this cytokine. In addition, microglia were shown to be the major source 
of TGFβ after stroke (Lehrmann et al., 1998), although other cells were reported to produce it 
after microglia depletion (Recasens, Shrivastava, Almolda, González, & Castellano, 2019). 
 Taken together, the results show that this genetic model for microglia depletion is a useful 
tool to further characterize the function of microglial cells in physiological and pathological 
contexts in the neonatal brain. Given the sexual dimorphism in both sham and HI mice 
following microglia depletion, and the unknown effects on specific inflammatory or injury-





PAPER 3: DEFINING A TIME WINDOW FOR NEUROPROTECTION AND GLIA 

























































To study whether caffeine exerted neuroprotection after HI and the duration of the 
therapeutic time window. 
Background: 
Caffeine is a competitive antagonist of the adenosine receptor. It is commonly used in the 
clinic to treat neonatal apnea and long-term follow-up in apneic children showed a reduced 
incidence of cerebral palsy.  
Hypothesis:  
Caffeine has a protective role if administered after neonatal HI.  
Results:  
Caffeine induces functional recovery and neuroprotection only when administered directly 
after HI. Later treatments do not have an effect. Caffeine reduces the number of amoeboid 
microglia and apoptotic cells, limits glial scar formation and white matter damage, and 




In Paper III we studied the effects of caffeine treatment after HI brain injury. A previous study 
from the Ådén group demonstrated that caffeine can offer neuroprotection and functional 
recovery in a mild form of neonatal HI (Winerdal et al., 2017). We therefore aimed to assess 
whether caffeine exerted the same effects in a more severe model of injury, and to define the 
caffeine therapeutic time window. 
 Specifically, we administered a single dose of 5mg/kg caffeine at 0, 6, 12 and 24 hours 
after HI, which was induced at P10, and performed behavioral studies starting from P21. Our 
results showed that while caffeine did not improve coordination in rotarod tests, it restored the 
behavioral deficits induced by HI in the open field test when administered acutely (0h). The 
animal activity during the test was indeed normalized to the level of the controls, suggesting 
habituation to the arena only at that time point.  
 Histological analyses also confirmed the previously observed neuroprotective effect of 
caffeine. We evaluated the extent of global injury by assigning a neuropathological score to 
cresyl violet-stained sections, and we defined the percentage of tissue loss by contouring MAP2 
unstained tissue. In both analyses the lesion was reduced only at the 0h time point, in concert 
with behavioral analyses. No difference was evident after later administrations. 
 Previous studies have reported amelioration in HI rodents after multiple injections or 
higher doses of caffeine (Alexander, Smith, Rosenkrantz, & Fitch, 2013; Potter, Rosenkrantz, 
& Fitch, 2018), but none of them had defined a therapeutic time window. In our study we 
therefore highlighted the importance of acutely administering caffeine after HI. Because no 
effect was observed when caffeine was administered at later time points, we decided to only 
proceed with further analysis with the 0 h treatment and we characterized the effects of caffeine 
5 days after HI.  
 We observed that MAP2 tissue loss was reduced after caffeine injection, mainly in the 
hippocampus and striatum, suggesting that caffeine neuroprotective mechanisms involved both 
adenosine A1 and A2A receptors. Indeed, adenosine A1 receptor is highly expressed in the 
hippocampus while adenosine A2A receptor is highly expressed in the striatum (Cunha, 2005). 
Delineation of GFAP reactive astrocytosis revealed perfect overlap with MAP2 unstained 
tissue. Similarly to the MAP2 analysis, the caffeine-treated group had a reduced glial scar in 
the hippocampus and striatum, and presented a less extensive astrogliosis in the cortices, 
specifically between layers 2/3 and, less prominently, in layer 5. Although no comparable 
MAP2 injury was observed in the cortices to justify the reactivity of astrocytes, an elevated 
number of TUNEL+ cells was instead associated with the extent of the glial scar. Since mice 
treated with caffeine had a lower number of TUNEL+ cells, as supported by others (Kilicdag, 
Daglioglu, Erdogan, & Zorludemir, 2014), the consequent smaller glial scar could be self-
explanatory. However, it was previously reported that caffeine selectively antagonizes 
adenosine A2A receptor in astrocytes, thereby affecting their immunoreactivity and 
proliferation (Desfrere et al., 2007), and this suggests a direct modulatory effect of caffeine.  
 To assess whether microglia were also modulated by a smaller lesion and reactive 
astrocytes, we performed Iba1 staining and analyzed cells with an amoeboid cell body. We 
determined that mice treated with caffeine had a lower number of amoeboid microglia in the 
striatum and cortices, and that the soma size of these cells was smaller than in the PBS-treated 
HI group. Recent findings demonstrated that caffeine can suppresses microglial production of 
pro-inflammatory mediators (Kang et al., 2012) that are associated with the M1 phenotype 
induced by adenosine (Colella et al., 2018). Similarly, activation of adenosine A2A receptor 
causes cytokines production and retraction of microglial processes, leading to the active state 
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(Minghetti et al., 2007; Orr, Orr, Li, Gross, & Traynelis, 2009) while blockade of this receptor 
reduces microglial activation (Rebola et al., 2011), also confirming caffeine modulatory effects 
on microglial cells. 
 Finally we analyzed the white matter (WM) damage and we demonstrated that caffeine 
specifically preserved myelination in the striatum, where a higher concentration of MBP+ fibers 
are detected. Hypoxia is known to alter the maturation of oligodendrocyte progenitors (OP) 
cells and thus affects myelination while conversely caffeine was shown to invert this process 
and to promote OP normal development by inhibiting the adenosine A1 receptor (Cao et al., 
2019; Othman, Yan, & Rivkees, 2003; Stevens, Porta, Haak, Gallo, & Fields, 2002). In support 
of our results, caffeine treatment was shown to enhance myelination in a model of 
periventricular WM injury (Back et al., 2006). 
 Caffeine binds to some extent to all adenosine receptors, with a preference for the 
adenosine A1 and A2A receptors that are expressed in the pre- and post- synaptic site of neurons, 
but that are also present in microglia, astrocytes and oligodendrocytes (Sheth, Brito et al. 2014). 
By binding to ARs, caffeine thus modulated the cells during injury, as our study has 
demonstrated. 
 Taken together, these results show beneficial effects of caffeine in the form of functional 
recovery and neuroprotection, after a single administration. As caffeine is currently used in the 
clinic to teat apneic babies (Aranda, Collinge, Zinman, & Watters, 1979) (Johnson, 2011; 
Natarajan, Lulic-Botica, & Aranda, 2007) and long-term follow-up studies have shown a 
reduction in the incidence of cerebral palsy in treated children (Schmidt et al., 2007), we 




PAPER 4: ADOPTIVE TRANSFER OF BONE-MARROW-DERIVED 
MACROPHAGES MODULATES POST-ISCHEMIC INFLAMMATION IN A MODEL 


















































To study the effects of an adoptive transfer of bone marrow-derived macrophages in 
different polarization states after HI. 
Background: 
Previous studies have investigated the therapeutic potential of different cells types, 
including monocytes, to treat neonatal HI. Macrophages have different polarization states 
depending on the signals they receive at the microenvironmental level, and are capable of 
immunomodulary activities.   
Hypothesis:  
Polarization of the cells used as treatment influences the injury outcomes.  
Results:  
Peripheral macrophages peak in the ipsilateral hemisphere 1 and 7 days after HI. Adoptive 
transfer of BMDMs differentially modulated the injury outcomes depending on the 
administered phenotype. M0 macrophages led to worsening of the behavioral performance, 
whereas M2 macrophages promoted functional recovery. Our in vitro results showed that 
M0 cells co-cultured with hippocampal organotypic slices subjected to OGD had an 
upregulation of pro-inflammatory genes, thus suggesting induction to an M1 phenotype. 
On the contrary, M2 cells maintained their anti-inflammatory state. 
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In Paper IV we studied the infiltration of peripheral macrophages in the injured brain after HI. 
We identified a biphasic pattern whereby RFP+ cells peak in the ipsilateral hemisphere after 1 
day and 7 days in injured animals. It is well known that immune cells reach the injury site 
shortly after HI and that their role is fundamental in the post-ischemic neuroinflammation 
(Hagberg et al., 2015; Lai et al., 2017). In accordance with previous studies reporting that 
infiltration of immune cells protracts in time (Bona et al., 1999; P. L. P. Smith et al., 2018; 
Winerdal et al., 2012), we also observed that the number of RFP+ cells in the ipsilateral 
hemisphere was higher than the controls up to 14 days post-HI. Increasing evidence of the role 
of chronic post-ischemic inflammation suggests that targeting this tertiary phase of disease with 
immunomodulatory therapies could promote neuroprotection and lead to tissue repair 
(Davidson et al., 2018; Fleiss & Gressens, 2012; Gliem et al., 2012).    
 Tissue-reparative processes indeed rely on factors such as resolution of inflammation and 
healing, and macrophages, which play a crucial role during HI inflammation, are capable of 
producing anti-inflammatory cytokines/chemokines and eliminating tissue debris (Harris, 
2014). The Harris lab previously demonstrated that simultaneous stimulation with IL-4/IL-
10/TGFβ could induced a stable anti-inflammatory phenotype (M2) in BMDMs and how, upon 
administration in diseased animals, such cells significantly modulated the disease progression 
in Type 1 diabetes (Parsa et al., 2012) and multiple sclerosis (X. M. Zhang, Lund, Mia, Parsa, 
& Harris, 2014) models. 
 Given the extensive recruitment of macrophages in our HI injury model, and therefore the 
extended time frame for a cell-based therapeutic approach, we decided to stimulate BMDMs 
ex vivo into an M2 phenotype and to inject these cells during the sub-chronic phase of HI 
inflammation. This approach was quite novel since no other study had so far evaluated the 
therapeutic potential of M2 cells in neonatal models of injury, although others have previously 
evaluated the effects of different sources of mononuclear cells as treatment for perinatal 
asphyxia (Sato et al., 2018; J. Zhang et al., 2019).  
 In our experimental design HI was performed at P10, and M2 or M0 cells were injected 
i.p at P15 and behavioral testing was performed between P31-P34. The time point for cell 
administration was chosen considering the infiltration window of peripheral macrophages. In 
addition, in order to distinguish between the effect of the cell type and the effect of the specific 
phenotype, we decided to use M0 cells as controls. This choice was of fundamental importance 
as we observed different outcomes depending on the type of cells administered. 
 The beam walk test showed that when mice received M2 macrophages after HI they 
performed better, making fewer mistakes than injured mice receiving PBS, indicating 
improvements in balance and fine movements. Conversely, worsening of the performance was 
observed when M0 macrophages were administered. Although we expected rotarod 
performance to concord with the beam walk, our results did not show any statistical difference 
in the treated mice. Injured animals performed worse than did shams, and M0 cells similarly 
led to a trend towards a poorer coordination performance compared to the PBS-treated mice. 
However, no improvement was observed in animals receiving M2. This is not the first case in 
which various behavioral tests assessing similar functions have resulted in different outcomes. 
Interestingly, findings similar to ours were previously observed in a study in which HI rats 
treated with bone marrow-derived mononuclear cells had a better performance in the gait-
CatWalk test, indicating an improved coordination, but no differences were observed in the 
rotarod test (Sato et al., 2018). 
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 Histological analysis aimed at assessing the extent of the lesion were partially in line with 
the behavioral tests. Cresyl violet-stained sections were used to assess the global injury using 
the NPS system, while tissue atrophy was measured by contouring unstained MAP-2 tissue. 
We determined that mice receiving M0 macrophages had a trend towards a larger injury and 
an increased tissue loss compared to HI mice treated with PBS. Surprisingly, no difference was 
observed in animals that received M2 macrophages. It was previously reported that, although 
human cord blood-derived mononuclear cells significantly reduced motor deficits in a model 
of neonatal HI, they failed to offer neuroprotection (Meier et al., 2006). 
 Neuroprotection may not be the modulatory role of M2 macrophages in our experimental 
design. Although M2 cells are generally associated with reduction of tissue damage, increased 
cell survival, and promotion of wound healing (Dey, Allen, & Hankey-Giblin, 2014; 
Mantovani et al., 2004), we hypothesize that they may have other functions in this specific 
context. Cross-talk between astrocyte proliferation and monocyte invasion was previously 
reported to reduce glial scarring in brain injury (Frik et al., 2018) and we suggest that M2 cells 
may thus have modulatory effects on astroglial scar formation.   
 Concerning the M0 cells, we instead hypothesize that, even though the treatment was 
performed during the sub-acute phase of HI, the injury microenvironment may have led to 
unpolarized macrophages shifting towards a pro-inflammatory phenotype. Macrophages are 
indeed known to have either harmful (M1) or healing (M2) roles depending on specific signals 
they receive in a specific context and at a specific disease stage (Harris 2014). Indeed, although 
the specific phenotypic memory of M2 cells seem to be maintained even when exposed to a 
highly pro-inflammatory environment, the same cannot be said for M0 cells (Italiani & 
Boraschi, 2014; Viola, Munari, Sánchez-Rodríguez, Scolaro, & Castegna, 2019). We thus 
performed OGD in organotypic hippocampal slices and co-cultured them with either M0 or 
M2 cells for 48h to assess the effect of a high cytotoxic environment on macrophages. Our 
results indicated a higher expression of pro-inflammatory genes in M0 cells, thus suggesting 
induction of a pro-inflammatory phenotype. In contrast, M2 cells were capable of maintaining 
their identity, confirming previous reports (Parsa et al., 2012).       
 Taken together, these results confirm that macrophages have a fundamental role in the 
post-ischemic inflammation, as supported by the fact that depletion of macrophages after stroke 
leads to increase injury (Gliem et al., 2012; Wattananit et al., 2016), and that macrophages 
might have a successful therapeutic value only if they are in the M2 phenotype, as supported 







Paper I.  
 Infiltrating macrophages peaked one day after injury and slowly decrease over time, 
whereas resident microglial numbers significantly increase one day and peak three days 
after HI.  
 Infiltrating macrophages were the drivers of the inflammatory cascade by expressing 
the majority of upregulated markers in the M1/M2, chemockines/cytokines, PRR and 
sensome families of genes.  
 Sexual dimorphism was observed three days after injury in both GFP+ and RFP+ cells  
 Downregulation of homeostatic genes was observed one day after injury in both sexes, 
but only in females at the 3-day timepoint suggesting that male microglia return faster 
to control levels. 
 
Paper II.  
 The genetic model for microglia depletion obtained by crossing Cx3cr1EYFP-CreER mice 
with RosaDTA mice led to 99% microglial ablation in neonatal mice. 
 HI brain injury did not lead to faster repopulation.  
 Resident microglia played a neuroprotective role early after neonatal hypoxic ischemia. 
 Aggravating effect of microglia depletion was predominant in males and was 
associated with lower levels of anti-inflammatory cytokines.  
 
Paper III.  
 The therapeutic time window of caffeine was very short. 
 A single dose of caffeine given acutely after HI led to: 
o reduced grey and white matter damage, and apoptotic cell density 
o decreased amoeboid microglia and the area of astrogliosis 
o modulation of the expression of pro-inflammatory cytokines   
o functional recovery in terms of restored open field activity 
 
Paper IV.  
 Peripheral macrophages infiltrated the CNS in a biphasic pattern, peaking in the 
ipsilateral hemisphere one and seven days after HI. 
 Adoptive transfer of M0 macrophages led to worsening of the behavioral performance 
and a tendency towards a larger injury as they shifted toward a pro-inflammatory 
phenotype. 
 Adoptive transfer of M2 macrophages promoted functional recovery by maintaining 





6 FUTURE PERSPECTIVES 
 
In my thesis we demonstrated that microglial cells have a protective role in the neonatal brain, 
that peripheral macrophages are the main players in post-ischemic inflammation, and that 
caffeine and M2 cells should be further investigated as potential therapeutic agents for HI brain 
injury.  
Based on our results, I suggest the following research questions to guide future experiments.  
 
Do resident microglia mature differently in males and females?  
As we demonstrated in Study I, microglial cells deriving from injured male hippocampi had 
an upregulation of homeostatic genes 3 days after HI compared to females. This sexual 
dimorphysm in the expression of signature genes suggests a different mechanistic response of 
microglial cells to brian injury. As clinical evidence and pre-clinical studies reported that males 
have a higher incidence of worse long-term outcomes in injuries associated with the perinatal 
period (Wood et al., 2005), further investigations are needed to determine whether this 
difference may be associated with microglia maturation, and if so whether it is causative (males 
are more affected because microglia matures differently) or consequential (microglia 
maturation in males is affected due to HI). A possibille analysis to determine microglial 
maturation could be the identification of the Microglia Developmental Index (MDI) as recently 
described by Hanamsagar and colleagues (Hanamsagar et al., 2017). By sequencing microglial 
cells from embryonic till adult mice the authors identified specific genes expressed in different 
developmental stages that could define an index of microglia maturation. Applying this MDI 
to human transcriptome data, they recorded disease-specific microglia development alterations 
and similarities with reported clinical studies concerning disease incidence. Thus, by analyzing 
the MDI in our data we could therefore deepen our understanding of the role of microglia in 
HI brain injury.  
 
What drives the post-ischemic inflammation after microglia depletion? 
In Study II we demonstrated that microglial depletion before HI brain injury leads to a larger 
infarction size and a higher number of apoptotic cells than in control mice. However, it is yet 
to be defined how cell debris is removed and inflammatory molecules to guide the post-
ischemic inflammation are produced when microglia are depleted. In addition, the role of other 
glial cells and infiltrating immune cells has not been investigated.  
 Recent findings have demonstrated that peripheral monocytes can colonize the adult brain 
after microglia depletion and acquire a microglial-like phenotype although maintaining a 
distinct transcriptional, functional and epigenetical diversity (Lund et al., 2018). This raises the 
question as to the origin of repopulating microglial cells in the neonatal brain, and the specific 
role of infiltrating macrophages when microglia are depleted. 
 
How do adoptively transferred macrophages lead to functional recovery? 
In Study IV we demonstrated that an adoptive transfer of M2 macrophages given at P15 
improves the behavioral performance of animals 3 weeks after HI. However, no difference in 
the lesion extent was observed between mice that received vehicle or cell treatment. Recent 
findings have shown a correlation between the extent of the astrocytic glial scar and the rate of 
infiltration of peripheral monocytes (Frik et al., 2018). The latter were reported to actively 
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modulate the composition of the extracellular matrix and the consequent formation of scarring 
tissue after traumatic-brain injury (Kjell & Götz, 2020). Since it is known that the glial scar is 
part of the tertiary phase of HI brain injury, we hypothesize that the modulatory effects of M2 
cells may be directly related to astrocytes.    
 
In general a lot can be learned from preclinical studies, but the road from rodent experiments 
to clinical practice is quite long. Therefore the next step towards identifying targets and specific 
mechanisms of recovery that may be exploited for therapeutic development would be to 
implement larger animal models. Although challenging, such an effort will aid in addressing 
the gap in translating bench science to bedside treatments. 
 Moreover, additional studies should be performed to evaluate the therapeutic potential of 
mononuclear cells derived from other sources, such as umbilical cord blood (UCB), 
differentiated into M2 macrophages. UCB is readily available at birth, and it could result in 
autologous treatment, thus reducing immunoreactivity risks of heterologous administrations 
(Castillo-Melendez et al., 2013). However no previous studies have evaluated the effects of 





It is unbelievable to think that I am almost done, considering that so much has happened during 
this PhD…a massive water leak, three lab-moves, and a world pandemic?!? This journey has 
finally reached an end and I wouldn’t be here if it wasn’t for my supervisors, colleagues, friends 
and family, and I owe them big thanks for their support!  
 
I am truly grateful to my supervisor Ulrika Ådén for giving me this opportunity. I remember 
our first meeting, during the selection process to fill the PhD position. You asked me something 
like “where do you see yourself in the future?” and I answered “in your chair, or better, not 
yours but another one, as group leader”. I was young and determined, and you were (are) many 
things: a woman, a doctor, a mother, a researcher, a musician…plenty to take inspiration from! 
Thank you for giving me independence and supporting me to develop as an independent 
researcher. 
 
I am deeply grateful also to my co-supervisors Klas Blomgren, Robert Harris, Ronny 
Wickström and Julianna Kele for their assistance and help during the past few years.   
Klas, although I changed PI it feels like I actually never left your group. I happily followed you 
from Gothenburg to Stockholm: I probably wouldn’t have had this position if it wasn’t for you. 
Working in your group has been fun!   
Bob, your kindness and perspective of things have helped more than you know. I truly 
appreciated when you removed your ‘supervisor hat’ and put on the ‘friend hat’ to talk about 
everything going on in my professional and at the times also private life. 
Ronny, although we have met few times your inputs on the projects have been spot on and 
efficiently guided me to the next step. 
Julianna, your perseverance and resilience are admirable. With time I have seen you under a 
different light, I would say that our relationship now goes beyond the work environment. 
 
I am truly thankful to all my collaborators, colleagues and students.  
I start with the latter because I think that supervising you - George, Mikaela, Marco, Luigi, 
Erica, Davide and Anne - has been one of the best things that could happen to me and you 
will always be in my heart! Although time consuming, teaching you shaped the researcher I 
am today: I learnt so much from your questions and your approach to science…thank you for 
this, and for the help you provided in the lab!  
 
Science is based on collaborations and I would be lost without the support of my precious 
collaborators. Thanks to Xingmei, Melanie and Jinming for helping me with the optimization 
of the flow cytometry protocol and for booking the FACS facility. Thanks to Volker, Daniel, 
Anoop and Ujjwal for the great help with the transcriptomic analysis and answering my so-
many-questions about sequencing. Thanks to Luis for always being so kind and flexible to run 
last-minute experiments whenever we have new pups. 
 
I feel I owe a big thank you to the staff of the animal facility: AKM has been my second home 
for years, with long experiments often in the middle of the night. The kindness and cheerfulness 
of the personnel has warmed my heart in many occasions. Thank you all for taking great care 
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of our mice and flexibly helping me even when I gave you short-notice. A special thanks goes 
to Sandra for being such a nice person, I will miss our talks about work and about life!  
 
And now my lovely colleagues: you guys had to deal with every shade of my personality during 
the PhD, in the good and bad, in the happy and sad, in relax and stress, etc. Although it hasn’t 
always been easy I am grateful you crossed my path! 
UÅ group: Shun and Takeo, thank you for bringing a piece of Japan into my life, and for 
sharing with me long hours and weekends in the lab: it felt like having guardian angels! 
Isabella, I wish we met sooner! You are a very nice person and I have enjoyed working with 
you. I hope this friendship will grow outside the lab! Thanks also to the UÅ dry lab colleagues, 
specifically Nelly, Lina, Marika and Jenny, for the nice chats back in the days when we were 
in ALB, and to Gustaf for his passion for science and helping with the CLARITY project!     
KB group: Ahmed, you are the North Star of the group! I owe you more than you know, so 
thank you for always being there, and answer all my silly questions. You have been a great 
friend and I know I can rely on you both personally and professionally! Adamantia, Yara, Ale 
and Alkis: thank you for bringing the South European warmth into the lab…as they say “put 
an Italian, a Greek and a Spanish in the same room and you have a party”! Kai and Cuicui, I 
cannot believe we met in Gothenburg eight years ago. Thank you for reminding me about the 
good times when we were just research assistants and life was easier! Asuka and Yasushi, 
thanks for your kindness and for reminding me we should have another Halloween party soon! 
Thanks also to previous members of the KB group - Vino, Takashi, Giulia, Cecilia, Shinobu 
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